Technical Analysis for PFNX - Pfenex Inc.

Grade Last Price % Change Price Change
grade B 5.1 3.87% 0.19
PFNX closed up 3.87 percent on Tuesday, March 19, 2019, on 1.15 times normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical PFNX trend table...

Date Alert Name Type % Chg
Mar 19 180 Bullish Setup Bullish Swing Setup 0.00%
Mar 19 Wide Bands Range Expansion 0.00%
Mar 18 Wide Bands Range Expansion 3.87%
Mar 15 1,2,3 Pullback Bullish Bullish Swing Setup 3.24%
Mar 15 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 3.24%
Mar 15 Upper Bollinger Band Walk Strength 3.24%
Mar 15 Inside Day Range Contraction 3.24%
Mar 15 Wide Bands Range Expansion 3.24%
Mar 15 Upper Bollinger Band Touch Strength 3.24%
Mar 14 Outside Day Range Expansion 2.82%

Older signals for PFNX ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Pfenex Inc., a clinical-stage biotechnology company, is engaged in the development of biosimilar therapeutics. Its lead product candidate includes PF582, a biosimilar candidate to Lucentis that is in Phase Ib/IIa trials in patients with wet age-related macular degeneration. The company also develops PF530, an interferon beta-1b biosimilar candidate to the Betaseron to reduce the relapses in patients with relapsing forms of multiple sclerosis; PF694, an interferon alpha-2a biosimilar candidate to the reference product Pegasys; and other biosimilar candidates. In addition, it develops PF708, a teriparatide generic peptide product candidate to the reference listed drug Forteo; Px563L, an anthrax vaccine candidate based on a recombinant modified form of the protective antigen; and Px533, a prophylactic vaccine candidate to protect against malaria infection. The company has collaboration with Strides Arcolab Limited for the development of PF530. Pfenex Inc. is headquartered in San Diego, California.
Medicine Biotechnology Life Sciences Biology Alpha Drugs Multiple Sclerosis Wet Age Related Macular Degeneration Anthrax Antivirals Biosimilar Interferon
Is PFNX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 8.42
52 Week Low 3.13
Average Volume 97,765
200-Day Moving Average 4.6345
50-Day Moving Average 4.129
20-Day Moving Average 4.5355
10-Day Moving Average 4.71
Average True Range 0.3489
ADX 45.61
+DI 31.0367
-DI 8.0632
Chandelier Exit (Long, 3 ATRs ) 4.2033
Chandelier Exit (Short, 3 ATRs ) 4.9767
Upper Bollinger Band 5.2866
Lower Bollinger Band 3.7844
Percent B (%b) 0.88
BandWidth 33.120935
MACD Line 0.2586
MACD Signal Line 0.2162
MACD Histogram 0.0424
Fundamentals Value
Market Cap 119.99 Million
Num Shares 23.5 Million
EPS 0.06
Price-to-Earnings (P/E) Ratio 85.00
Price-to-Sales 1.08
Price-to-Book 1.09
PEG Ratio -0.03
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.48
Resistance 3 (R3) 5.44 5.29 5.41
Resistance 2 (R2) 5.29 5.19 5.30 5.39
Resistance 1 (R1) 5.19 5.13 5.24 5.23 5.37
Pivot Point 5.04 5.04 5.06 5.05 5.04
Support 1 (S1) 4.94 4.94 4.99 4.98 4.83
Support 2 (S2) 4.79 4.88 4.80 4.81
Support 3 (S3) 4.69 4.79 4.79
Support 4 (S4) 4.73